Brief: Aytu Bioscience Inc - On January 20, 2021, Co Signed An Exclusive License Agreement
Jan 25 (Reuters) - Aytu BioScience Inc AYTU.O :
* AYTU BIOSCIENCE INC - ON JANUARY 20, 2021, CO SIGNED AN
EXCLUSIVE LICENSE AGREEMENT
* AYTU BIOSCIENCE- AGREEMENT TO LICENSE INTELLECTUAL
PROPERTY
SURROUNDING USE AND COMMERCIALIZATION OF RAPID IN VITRO
DIAGNOSTIC SEMEN ANALYSIS TEST
* AYTU BIOSCIENCE- AGREEMENT HAS BEEN ENTERED INTO WITH
AVRIO
GENETICS, LLC
Source text for Eikon: [https://bit.ly/2YdtWxc]
Further company coverage: AYTU.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aytu Biopharma
See all newsAytu Biopharma Inc reports results for the quarter ended March 31 - Earnings Summary
Aytu BioPharma Q4 revenue beats analyst estimates on EXXUA sales
Aytu Biopharma Inc expected to post a loss of 32 cents a share - Earnings Preview
Aytu BioPharma Q3 revenue falls amid EXXUA launch
Aytu BioPharma Q2 revenue beats expectations